Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
- |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Targacept Inc
Targacept Inc is a biopharmaceutical company based in the United States. The company is focused on developing drugs that target specific neuronal receptors to treat various diseases and disorders. They specialize in developing drugs for the central nervous system, with a particular focus on conditions such as Alzheimer's disease, major depressive disorder, and schizophrenia.
Targacept's approach involves leveraging their expertise in neuroscience research and utilizing cutting-edge technologies to identify and develop novel drug candidates. They aim to address unmet medical needs and improve patient outcomes through their innovative therapies.
The company has a diverse pipeline of drug candidates in various stages of development. They collaborate with academic institutions, medical centers, and other pharmaceutical companies to advance their research and bring their drugs to market.
Targacept Inc has a commitment to scientific excellence and a mission to make a meaningful impact on patients' lives. Through their research and development efforts, they strive to discover breakthrough treatments for neurological and psychiatric disorders.
|